Malignant hyperthermia (literature review)

The objective – to summarize the current literature data on the etiology, pathogenesis, diagnosis and treatment of malignant hyperthermia.   The search and analysis of literature data on malignant hyperthermia in the medical information systems PubMed, Сochrane librarу, Cyberleninka for the last 10...

Full description

Saved in:
Bibliographic Details
Main Authors: R. R. Tukhvatullina, N. V. Matinyan
Format: Article
Language:Russian
Published: New Terra Publishing House 2023-05-01
Series:Вестник анестезиологии и реаниматологии
Subjects:
Online Access:https://www.vair-journal.com/jour/article/view/752
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850028823148494848
author R. R. Tukhvatullina
N. V. Matinyan
author_facet R. R. Tukhvatullina
N. V. Matinyan
author_sort R. R. Tukhvatullina
collection DOAJ
description The objective – to summarize the current literature data on the etiology, pathogenesis, diagnosis and treatment of malignant hyperthermia.   The search and analysis of literature data on malignant hyperthermia in the medical information systems PubMed, Сochrane librarу, Cyberleninka for the last 10 years was performed with using the keywords: «malignant hyperthermia», «dantrolene», «general anesthesia», «succinylcholine», «inhalation anesthetics». The search criteria were met by 96 publications. In addition, references to selected articles were manually checked for applicable articles including recent reports of malignant hyperthermia, in addition to works of historical significance. It was shown that malignant hyperthermia develops in susceptible individuals during or after general anesthesia with the use of trigger agents – inhaled halogen-containing anesthetics and succinylcholine. Until recently, the problem of treatment in Russia remained unresolved, since specific therapy for this syndrome was not available. In connection with the official registration of Dantrolene in the Russian Federation, this problem no longer has a life-threatening potential. Doctors should recognize the symptoms of this disease as early as possible in order to quickly begin the pathogenetic treatment of malignant hyperthermia in order to prevent fatal complications. The material is intended for a wide audience of anesthesiologists, resuscitators and surgeons who may encounter this pathology in clinical practice.
format Article
id doaj-art-e35489bead5e45d5823aa8f2990fbb5e
institution DOAJ
issn 2078-5658
2541-8653
language Russian
publishDate 2023-05-01
publisher New Terra Publishing House
record_format Article
series Вестник анестезиологии и реаниматологии
spelling doaj-art-e35489bead5e45d5823aa8f2990fbb5e2025-08-20T02:59:42ZrusNew Terra Publishing HouseВестник анестезиологии и реаниматологии2078-56582541-86532023-05-01202788410.24884/2078-5658-2023-20-2-78-84583Malignant hyperthermia (literature review)R. R. Tukhvatullina0N. V. Matinyan1Research Institute of Pediatric Oncology and Hematology of N. N. Blokhin National Medical Research Center of OncologyResearch Institute of Pediatric Oncology and Hematology of N. N. Blokhin National Medical Research Center of Oncology; Pirogov Russian National Research Medical UniversityThe objective – to summarize the current literature data on the etiology, pathogenesis, diagnosis and treatment of malignant hyperthermia.   The search and analysis of literature data on malignant hyperthermia in the medical information systems PubMed, Сochrane librarу, Cyberleninka for the last 10 years was performed with using the keywords: «malignant hyperthermia», «dantrolene», «general anesthesia», «succinylcholine», «inhalation anesthetics». The search criteria were met by 96 publications. In addition, references to selected articles were manually checked for applicable articles including recent reports of malignant hyperthermia, in addition to works of historical significance. It was shown that malignant hyperthermia develops in susceptible individuals during or after general anesthesia with the use of trigger agents – inhaled halogen-containing anesthetics and succinylcholine. Until recently, the problem of treatment in Russia remained unresolved, since specific therapy for this syndrome was not available. In connection with the official registration of Dantrolene in the Russian Federation, this problem no longer has a life-threatening potential. Doctors should recognize the symptoms of this disease as early as possible in order to quickly begin the pathogenetic treatment of malignant hyperthermia in order to prevent fatal complications. The material is intended for a wide audience of anesthesiologists, resuscitators and surgeons who may encounter this pathology in clinical practice.https://www.vair-journal.com/jour/article/view/752malignant hyperthermiadantrolenegeneral anesthesiasuccinylcholineinhalation anesthetics
spellingShingle R. R. Tukhvatullina
N. V. Matinyan
Malignant hyperthermia (literature review)
Вестник анестезиологии и реаниматологии
malignant hyperthermia
dantrolene
general anesthesia
succinylcholine
inhalation anesthetics
title Malignant hyperthermia (literature review)
title_full Malignant hyperthermia (literature review)
title_fullStr Malignant hyperthermia (literature review)
title_full_unstemmed Malignant hyperthermia (literature review)
title_short Malignant hyperthermia (literature review)
title_sort malignant hyperthermia literature review
topic malignant hyperthermia
dantrolene
general anesthesia
succinylcholine
inhalation anesthetics
url https://www.vair-journal.com/jour/article/view/752
work_keys_str_mv AT rrtukhvatullina malignanthyperthermialiteraturereview
AT nvmatinyan malignanthyperthermialiteraturereview